FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1920211000001105: Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25464101000001115 Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
111511201000001113 Erythrocin 500 tablets (Advanz Pharma) 100 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Is a Erythromycin stearate 500mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Is pack of Erythrocin 500 tablets (Abbott Laboratories Ltd) false Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has active ingredient Erythromycin stearate false Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has AMP Erythrocin 500 tablets (Abbott Laboratories Ltd) true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has specific active ingredient Erythromycin stearate true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Erythrocin 500 tablets (Abbott Laboratories Ltd) 100 tablet Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start